Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
1/2/2025
Hutchmed Announces $608M Non-core Chinese Unit Stake Sale
1/2/2025
Roche and Innovent Enter Global License Deal for Novel DLL3 ADC
12/30/2024
Reforgene Secures Major Financing to Advance Gene-Editing Therapies
12/30/2024
CARsgen Reports Positive Topline Results from China GC/GEJ Pivotal Pha...
12/30/2024
Duality Announces B7H4 ADC Milestone and License Exercise by BeiGene
12/30/2024
Solasia Struggles to Finalize China Deal, Lowers 2024 Financial Guidan...
12/30/2024
India Deepens Ties with Chinese Biotech: Cipla and Mankind Lead the W...
12/29/2024
CSRC Approves Ascentage Pharma's U.S. IPO Filing
12/29/2024
Hong Kong Accepts IPO Application from GenFleet Therapeutics
12/29/2024
IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for AD...
12/27/2024
AusperBio Secures $73M in Series B Financing to Advance Functional Cur...
12/25/2024
Huaota Biopharma Secures CNY 200M in Financing to Drive R&D
12/25/2024
Hechuang Biotech Secures Series A Funding to Advance CGT Research
12/25/2024
Eli Radiopharma Raises Funds to Accelerate Radiopharma Innovations
12/24/2024
Sanofi Reaffirms Commitment to China's Growing Biopharmaceutical Secto...
12/24/2024
Fosun Pharma's Parent Company Pledges 27% of Its A-shares
12/24/2024
WuXi Biologics to Divest Advanced Therapies Unit Amid U.S. Restriction...
12/24/2024
Ascentage Pharma Secures Chinese Regulatory Approval for U.S. Nasdaq ...
12/23/2024
RAPT Thera and Jemincare Enter License Deal for Novel Long-Acting an...
12/23/2024
CORXEL Acquires ex-Greater China Rights to an Oral Small Molecule GLP...
12/23/2024
Roch Secures Chinese Approval of Lunsumio (Mosunetuzumab) for r/r Fol...
12/23/2024
MSD Finalizes Exclusive Global License Deal for Anti-PD-1 LM-299
12/23/2024
Sanofi Acquires Rights to Cytokinetics's Aficamten in Greater China
12/23/2024
Shionogi Acquires Pingan's Stake in AI-Focused JVs
12/19/2024
BMS China Regains Rights to GPC3 Targeted Drug ABZ-706 in Greater Chin...
12/19/2024
Palleon and Henlius Collaborate to Advance Glycan Editing for Autoimmu...
12/19/2024
Aadi Partners with WuXi Bio and DAC for Next-Gen ADCs, Secures $100M P...
12/18/2024
BMS and Fangzhou Forge Strategic Alliance to Advance Digital Healthcar...
12/18/2024
IFC Proposes $200M Loan to 3SBio to Improve Access in China and Develo...
12/18/2024
Merck and Hansoh Enter into Global License Deal for Investigational Or...
Page:
11
/
23
Total number of articles:
663
:
[First]
[<<]
[9]
[10]
[11]
[12]
[13]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit